Longeveron Inc. (LGVN)
Longeveron Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Longeveron Inc. (LGVN) is a Biotechnology company based in US with a market capitalization of $15.4M. Revenue declined 49.9% year-over-year and free cash flow was negative at -$18.9M. This page tracks LGVN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 25 employees · IPO Feb 12, 2021
Valuation
Valuation & price
$0.67as of May 17, 2026· -61.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.72
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$15.4M
Market cap
-49.9%
Revenue growth (YoY)
67.0%
Gross margin
-$18.9M
Free cash flow (USD)
-$3.8M
Net debt
Net cash position
18.0%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2018 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 13, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Longeveron Inc.'s market cap?
Longeveron Inc. (LGVN) has a market capitalization of $15.4M.
What is LGVN's P/E ratio?
A meaningful P/E ratio is not available for LGVN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is LGVN's price-to-book (P/B) ratio?
LGVN trades at 2.72 times book value per share.
Are insiders buying LGVN stock?
SEC Form 4 filings show no open-market insider buys at Longeveron Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.